NanoViricides
NNVC
#10090
Rank
S$33.39 M
Marketcap
S$1.86
Share price
16.26%
Change (1 day)
-7.14%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$1.69 Million

According to NanoViricides's latest financial reports the company's total liabilities are S$1.69 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30S$1.84 M-33.08%
2023-06-30S$2.75 M379.27%
2022-06-30S$0.57 M21.54%
2021-06-30S$0.47 M-84.29%
2020-06-30S$3 M-21.94%
2019-06-30S$3.85 M220.31%
2018-06-30S$1.2 M-86.93%
2017-06-30S$9.19 M-49.75%
2016-06-30S$18.3 M9.53%
2015-06-30S$16.7 M-34.59%
2014-06-30S$25.54 M139.71%
2013-06-30S$10.65 M372.61%
2012-06-30S$2.25 M212.93%
2011-06-30S$0.72 M-79.02%
2010-06-30S$3.43 M361.09%
2009-06-30S$0.74 M-46.57%
2008-06-30S$1.39 M6.95%
2007-06-30S$1.3 M-45.07%
2006-06-30S$2.37 M2023.58%
2005-06-30S$0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
S$1.08 B 63,757.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.73 B 102,199.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$48.11 B 2,837,744.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.59 B 5,992,077.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.74 B 5,942,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.52 B 4,690,559.16%๐Ÿ‡ฌ๐Ÿ‡ง UK